Close
UCL, together with its partner hospitals, has successfully established itself as a leading global centre for developing and trialling next-generation advanced medical therapies, according to a report from the UCL Translational Research Office and UCL Business Ltd.
In this video, Dr Jane Kinghorn, Director of the UCL Translational Research Office, discusses what sets UCL apart from other academic institutions and how UCL supports researchers in bringing ATMPs to patients. Dr Anne Lane, CEO of UCL Business, explains how UCL Business supports the commercialisation of ATMPs and addresses the associated challenges.